Voxy review
The figure in the headline belongs to the twelve-month plan, and every other rung is published beside it.
The verdict
Voxy publishes $179 a month for compounded semaglutide, with a headline of starting at $129 that belongs to the annual prepay tier. Every rung of the ladder is published.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- From
- From $179/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Voxy sells both molecules by injection across four billing cadences. The price covers the provider visit, medication, injection supplies, shipping and monthly check-ins.
Who writes the prescription, and what do they see?
Monthly check-ins are named as included, which is a specific commitment about the clinical relationship rather than a general one. The clinician is not otherwise described.
Five things inside one figure is a broad inclusion list, and monthly check-ins in particular are rare. The headline choosing the lowest rung is the usual pattern, and the other rungs being published beside it is not.
What happens when the dose goes up?
Nothing states what any rung does at a higher dose. The ladder is about billing cadence rather than milligrams, so the escalation question is unanswered on all four rungs equally.
What the price includes
Semaglutide runs $179 month to month, $159 billed quarterly, $149 billed every six months and $129 billed annually. Tirzepatide runs $299, $269, $239 and $199. The annual rung is 28 percent below the monthly on semaglutide and 33 percent on tirzepatide.
What it claims, and what it cites
Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.
Where it holds up, and where it does not
- Strength: All four cadences published
- Strength: Monthly check-ins named as included
- Strength: Visit, supplies and shipping inside the price
- Limitation: The headline is the annual tier
- Limitation: Month to month costs $50 more
- Limitation: No dose behavior is published
- Limitation: No state coverage list is recorded
What the evidence says about this kind of treatment
The assessment above is about Voxy. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who wants check-ins included and will pick a cadence deliberately.
- Wrong for
- A reader planning monthly from the headline figure.
The evidence behind what Voxy prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How Voxy compares
| Seller | Who it suits | Go |
|---|---|---|
 VitaStir | Readers who will price the rung they expect to reach rather than the entry one | See VitaStir → |
 Whoosh Wellness | Readers unsure of eligibility who do not want to risk a consultation fee | See Whoosh Wellness → |
 VyrarX | Readers who will ask what maintenance costs before starting | See VyrarX → |
More GLP-1 telehealth sellers reviews: Superior RemediesSuperpowerSurpassMDSynergenX HealthSynergy RxT2D.com
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Is $129 a monthly rate?
- It is the twelve-month prepay tier. Month to month is $179 for semaglutide.
- What is included?
- The provider visit, medication, injection supplies, shipping and monthly check-ins.
- What are the middle rungs?
- $159 billed quarterly and $149 billed every six months on semaglutide.
- Is Voxy expensive compared with other GLP-1 telehealth sellers?
- Voxy publishes a starting figure of $179/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Voxy below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.